{'fraction_non_alphanumeric': 0.013052208835341365, 'fraction_numerical': 0.014056224899598393, 'mean_word_length': 5.5130718954248366, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Editorial for issue 3 of 2010, Journal of Evidence Based Medicine

We are pleased to bring you a mixture of original research, summaries of research from elsewhere and guidance in this issue of the Journal of Evidence Based Medicine. For example, in the following pages, you will find a systematic review by Li Zhang and colleagues from Tianjin University of Traditional Chinese Medicine using information from more than 1800 clinical studies investigating adverse drug reactions to shenmai injection, which is extracted from ginseng and ophiopogonis. A second systematic review, drawing on 645 articles with a total 1232 cases, investigates adverse reactions to Houttuynia injection. You can also read the words of the authors of three recent Cochrane reviews, summarising the evidence on suture materials for primary repair of episiotomy, different ways of administering insulin for type 1 diabetes mellitus, and medical versus surgical management for gastro-oesophageal reflux disease. A report on risk factors for drug resistance in pulmonary tuberculosis inpatients uses the medical records of 330 patients in Chengdu Tuberculosis Hospital from 2005 to 2007. It highlights the importance of more personalized treatment and supervision, and better training for medical staff to minimize the development of resistance. Guidance for the conduct, use and reporting of research comes from our education section which discusses the importance of core outcome measures in clinical research, a methodological framework for preparing economic evidence for the selection of medicines in the Chinese setting, and the extension of the CONSORT statement to clinical trials of acupuncture. These revised STRICTA (STandards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines are being published in several journals to maximise awareness about the need for clear reporting of these studies, and we ask all authors submitting such reports to the Journal to follow these guidelines.